Meet the editor

Keun-Yeong Jeong serves as the chief executive officer and chief technology officer of PearlsinMires. He received his Ph.D. in Medicine from Korea University and a BS in Biochemistry from Chungbuk National University, South Korea. He completed his postdoctoral fellowship at Yonsei University College of Medicine, South Korea. Prior to founding PearlsinMires, Dr. Jeong focused on investigating the treatment of cancer and general

diseases. He has noticeable scientific achievements to his credit, including many peer-reviewed publications and patents. Dr. Jeong developed promotion methods for the treatment of solid cancers utilizing stem cells, radiation, and peptides. He is the founder of PearlsinMires and a primary contributor to a core technology related to the company's anticancer drug platform.
